Product NDC: | 64455-771 |
Proprietary Name: | Cardizem |
Non Proprietary Name: | Diltiazem Hydrochloride |
Active Ingredient(s): | 30 mg/1 & nbsp; Diltiazem Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64455-771 |
Labeler Name: | BTA Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018602 |
Marketing Category: | NDA |
Start Marketing Date: | 20101225 |
Package NDC: | 64455-771-55 |
Package Description: | 500 TABLET, COATED in 1 BOTTLE (64455-771-55) |
NDC Code | 64455-771-55 |
Proprietary Name | Cardizem |
Package Description | 500 TABLET, COATED in 1 BOTTLE (64455-771-55) |
Product NDC | 64455-771 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Diltiazem Hydrochloride |
Dosage Form Name | TABLET, COATED |
Route Name | ORAL |
Start Marketing Date | 20101225 |
Marketing Category Name | NDA |
Labeler Name | BTA Pharmaceuticals |
Substance Name | DILTIAZEM HYDROCHLORIDE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |